Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with 'sawtooth' strategy

Annals of the Rheumatic Diseases

Volumn 57, Issue 9, 1998, Pages 533-539

  Mottonen T ^a   Paimela, L ^b   Leirisalo Repo, M ^c   Kautiainen, H ^d   Ilonen, J ^e   Hannonen, P ^f  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b Malmi Hospital   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d Finland MedCare Ltd   (Finland)

^e Universität Turku   (Finland)

^f JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; HEMOGLOBIN; HLA DR1 ANTIGEN; HLA DR4 ANTIGEN; RHEUMATOID FACTOR;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; GENETIC MARKER; GRIP STRENGTH; HUMAN; JOINT STIFFNESS; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REGRESSION ANALYSIS; REMISSION; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; TREATMENT OUTCOME;

EID: 0031695859     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.57.9.533     Document Type: Article

References (63)

1. Kushner I. Does aggressive therapy of rheumatoid arthritis affect outcome? J Rheumatol 1989;16:1-4.
2. Wolfe F. 50 years of antirheumatic therapy: the prognosis of rheumatoid arthritis. J Rheumatol 1990; 17:24-32.
3. Pincus T, Callahan LF. What is the natural historv of rheumatoid arthritis? Rheum Dis Clin North Am 1993;19:123-51.
4. Luukkainen R, Kajander A, Isomaki H. Effect of gold on progression of erosions in rheumatoid arthritis. Better results with early treatment. Scand J Rheumatol 1977;6:189-92.
5. van der Heijde DMFM, van Riel PL, Nuver-Zwart IH, van de Putte LBA. Sulphasalazine versus hydroxychloroquine in rheumatoid arthritis: 3-years follow-up. Lancet 1990; 335:534.
6. Borg G, Allander F, Berg E, Brodin U, Trang L. Auranofin treatment in early rheumatoid arthritis may postpone early retirement. Results from a 2-year double blind trial. J Rheumatol 1991;18:1015-20.
7. Hannonen P, Möttönen T, Hakola M, Oka M. Sulfasalazine in early rheumatoid arthritis. A double blind, 48 week prospective, placebo controlled study. Arthritis Rheum 1993; 36:1501-9.
8. Wilske KR, Healey LA. Remodeling the pyramid-a concept whose time has come. J Rheumatol 1989;16:565-7.
9. Fries JF. Reevaluating the therapeutic approach to rheumatoid arthritis: the "sawtooth" strategy. J Rheumatol 1990;17:12-15.
10. American college of rheumatology ad hoc committee on clinical guidelines: Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 1996;39:713-22.
11. Masi AF, Maldonado-Cocco JA, Kaplan SB, Feigenbaum SL, Chandler RW. Prospective study of the early course of rheumatoid arthritis in young adults: Comparison of patients with and without rheumatoid factor positivity at entry and identification of variables correlating to outcome. Semin Arthritis Rheum 1976;5:299-326.
12. van der Heijde DM, van Riel PL, van Rijswijk MH, van de Putte LB. Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature. Semin Arthritis Rheum 1988;17:284-92.
13. Willkens RF. Prognostic staging for therapy of rheumatoid arthritis. Semin Arthritis Rheum 1991;21 (suppl 1):40-3.
14. Wollheim FA, Eberhardt KB. The search for laboratory measures of outcome in rheumatoid arthritis. Baillieres Clin Rheumatol 1992;6:69-93.
15. Hochberg MC. Predicting the prognosis of patients with rheumatoid arthritis: is there a crystal ball? J Rheumatol 1993;20:1265-7.
16. Furst DE. Predictors of worsening clinical variables and outcomes in rheumatoid arthritis. Rheum Dis Clin North Am 1994;20:309-19.
17. Young A, Jaraquemada D, Awad J, Festenstein H, Corbett M, Hay FC, et al. Association of HLA-DR4/Dw4 and DR2/Dw2 with radiologic changes in a prospective study of patients with rheumatoid arthritis: preferential relationship with HLA-Dw rather than HLA-DR specificities. Arthritis Rheum 1984;27:20-5.
18. Weyand CM, Hicok KC, Conn DL, Goronzy JJ. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992;117:801-6.
19. Gough A, Faint J, Salmon M, Hassell A, Wordsworth P, Pilling D, et al. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 1994;37:1160-70.
20. Fex E, Jonsson K, Johnson U, Eberhardt K. Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort. Br J Rheumatol 1996;35:1106-15.
21. Eberhardt K, Fex E, Johnson U, Wollheim FA. Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis. Ann Rheum Dis 1996;55: 34-9.
22. Reveille JD, Alarcon GS, Fowler SE, Pillemer SR, Neuner R, Clegg DO, et al for the MIRA trial group. HLA-DRB1 genes and disease severity in rheumatoid arthritis. Arthritis Rheum 1996;39:1802-7.
23. Symmons DP, Ollier WE, Brennan P, Silman AJ. Should patients with recent onset rheumatoid arthritis be offered genetic screening? Ann Rheum Dis 1996;55:407-10.
24. Young A. Short term outcomes in recent onset rheumatoid arthritis. Br J Rheumatol 1995;34 (suppl 2):79-86.
25. Möttönen T, Paimela L, Ahonen J, Helve T, Hannonen P, Leirisalo-Repo M. Outcome in patients with early rheumatoid arthritis treated according to the "sawtooth" strategy. Arthritis Rheum 1996;39:996-1005.
26. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;131:315-28.
27. Möttönen TT. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 1988;47:648-53.
28. Paimela L, Leirisalo-Repo M, Helve T, Koskimies S. The prognostic value of HLA DR4 and B27 antigens in early rheumatoid arthritis. Scand J Rheumatol 1993;22:220-4.
29. Mallya RK, Mace BEW. The assessment of disease activity in rheumatoid arthritis using a multivariate analysis. Rheumatol Rehabil 1981;20:14-17.
30. Ritchie DM, Doyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;37:393-406.
31. Pinals RS, Masi AT, Larsen RA. The Subcommittee for Criteria of Remission in Rheumatoid Arthritis of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981; 24:1308-15.
32. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 1977;18:481-91.
33. Steinbrocker O, Traeger CH, Battermann RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
34. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23: 137-45.
35. Ilonen J, Lagerstedt A, Koskimies S, Reunanen M. HLA-Dw1 and BfF1 as protective markers in multiple sclerosis. J Neuroimmunol 1983;5:283-8.
36. Gran JT, Husby G, Thorsby E. The association between rheumatoid arthritis and the HLA antigen DR4. Ann Rheum Dis 1983;42:292-6.
37. Silman AJ, Reeback J, Jaraquemada D. HLA-DR4 as a predictor of outcome three years after onset of rheumatoid arthritis. Rheumatol Int 1986;6:233-5.
38. van der Heijde DMFM, van Riel PLCM, van Leemven MA, van't Hof MA, van Rijswijk MH, van de Putte LBA. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A Prospective follow-up study of 147 patients. Br J Rheumatol 1992;31: 519-25.
39. Calin A, Elswood J, Klouda PT. Destructive arthritis rheumatoid factor, and HLA-DR4: susceptibility versus severity, a case-control study. Arthritis Rheum 1989;32: 1221-5.
40. van Zeben D, Hazes JMW, Zwinderman AH, Cats A, Schreuder GMT, D'amaro J, et al. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Arthritis Rheum 1991; 34:822-30.
41. Hakala M, Silvennoinen-Kassinen S, Ikäheimo I, Isosomppi J, Tiilikainen A. HLA markers in a community-based rheumatoid arthritis series. Ann Med 1997;29:291-6.
42. Emery P, Salmon M. Early rheumatoid arthritis: time to aim for remission? Ann Rheum Dis 1995;54:944-7.
43. Amos RS, Constable TJ, Crockson RA, McConkey B. Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. BMJ 1977;1:195-7.
44. Dawes PT, Fowler PD, Jackson R, Collins M, Shadwoth MF, Stone R, et al. Prediction of progressive joint damage in patients with rheumatoid arthritis receiving gold or d-penisillamine therapy. Ann Rheum Dis 1986;45:945-9.
45. Westedt ML, Daha MR, Balwin WH, Stijnen T, Cats A. Serum immune complexes containing IgA appear to predict erosive arthritis in a longitudinal study in rheumatoid arthritis. Ann Rheum Dis 1986;45:809-15.
46. Young A, van der Heijde DMFM. Can we predict aggressive disease? Bailliers Clin Rheumatol 1997;11:27-48.
47. Luukkainen R, Kaarela K, Isomaki H, Martio J, Kiviniemi P. The prediction of radiological destruction during the early stage of rheumatoid arthritis. Clin Expl Rheumatol 1983;1:295-8.
48. Kaarela K. Prognostic factors and diagnostic criteria in early rheumatoid arthritis. Scand J Rheumatol 1985;14 (suppl 57):1-54.
49. Sherrer YS, Bloch DA, Mitchell DM, Young DY, Fries JF. The development of disability in rheumatoid arthritis. Arthritis Rheum 1986;29:494-500.
50. Scott DL, Coulton BL, Symmons D, Popert A. Long-term outcome of treating rheumatoid arthritis: Results after 20 years. Lancet 1987;i:1108-11.
51. van Schaardenburg D, Hazes JM, de Boers A, Zwinderman AH, Meijers KA, Breedveld FC. Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis. J Rheumatol 1993;20:45-52.
52. Young A, Corbett M, Winfield J, Jaqueremanda D, Williams, P, Papasavvas G, et al. A prognostic index for erosive changes in the hands, feet, and cervical spines in early rheumatoid arthritis. Br J Rheumatol 1988;27:94-101.
53. van der Heijde DMFM, van Leeuwen MA, van Riel PLCM, Koster AM, van't Hof MA, van Rijswijk MH, et al. Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum 1992;35:26-34.
54. van Zeben D, Hazes JMW, Zwinderman AH, Vandenbroucke JP, Breedveld FC. Factors predicting outcome of rheumatoid arthritis: results of a followup study. J Rheumatol 1993;20:1288-96.
55. van Leeuwen MA, van der Heijde DMFM, van Rijswijk MH, Houtman PM, van Riel PLCM, van de Putte LBA, et al. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. J Rheumatol 1994;21:425-9.
56. Fleming A, Crown JM, Corbett M. Prognostic value of early features in rheumatoid disease. BMJ 1976;1:1243-5.
57. Jacoby RK, Jayson MIV, Cosh JA. Onset, early stages, and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11-year follow-up. BMJ 1973;2:96-100.
58. Eberhardt KB, Rydgren LC, Petterson H, Wollheim FA. Early rheumatoid arthritis: onset, course, and outcome over 2 years. Rheumatol Int 1990;10:135-42.
59. van der Heide A, Jacobs JWG, Haanen HCM, Bijlsma JWJ. Is it possible to predict the first year extent of pain and disability for patients with rheumatoid arthritis? J Rheumatol 1995;22:1466-70.
60. Harrison BJ, Symmons DPM, Brenman P, Bankhead CR, Barrett EM, Scott DGI, et al. Inflammatory polyarthritis in the community is not a benign disease: Predicting functional disability one year after presentation. J Rheumatol 1996;23:1326-31.
61. Fuchs HA, Callahan LF, Kaye JJ, Brooks RH, Nance EP, Pincus T. Radiographic and joint count findings of the hand in rheumatoid arthritis. Arthritis Rheum 1988;31:44-51.
62. Kaarela K, Sarna S. Correlation between clinical facets of outcome in rheumatoid arthritis. Clin Exp Rheumatol 1993;11:643-4.
63. Hakala M, Nieminen P, Manelius J. Joint impairment is strongly correlated with disability measured by self-report questionnaires. Functional status assessment of individuals with rheumatoid arthritis in a population based series. J Rheumatol 1993;21:64-9.